This bill amends various sections of Alaska's pharmacy laws to enhance the role of pharmacists in patient care through collaborative practice agreements. It prohibits the state department or board from requiring fees for entering into these agreements, mandates that they cannot define the scope of services provided under such agreements, and removes the need for board approval. Additionally, the bill clarifies that pharmacists can independently provide patient care services for general health, disease prevention, and certain minor conditions, while also establishing new definitions and requirements for patient care services, including the prescription and administration of drugs.

Furthermore, the bill introduces new educational requirements for pharmacists, including training in pain management and opioid use, and modifies the reciprocity process for licensing pharmacists from other jurisdictions. It also emphasizes the importance of recognizing the limits of a pharmacist's education and experience when prescribing or administering medications. The changes aim to streamline the practice of pharmacy in Alaska while ensuring that pharmacists are adequately trained to handle the complexities of patient care, particularly in the context of opioid management. The act is set to take effect on January 1, 2027.

Statutes affected:
HB0195A, AM HB 195, introduced 04/15/2025: 08.80.030, 17.30.200, 08.80.168, 17.22.020, 17.20.085, 08.80.159, 08.80.110, 08.80.145, 08.80.165, 08.80.337, 08.80.480
HB0195B, AM CSHB 195(L&C), introduced 02/18/2026: 08.80.337, 08.80.030, 17.30.200, 08.80.168, 17.22.020, 17.20.085, 08.80.159, 08.80.110, 08.80.145, 08.80.165, 08.80.480